Christine Blank
Survey uncovers lupus corticosteroid treatment issues
Patients with systemic lupus erythematosus often self-manage their corticosteroid medication without the consent of their healthcare providers, according to a recent multicountry survey.
FDA takes tough stance on kids’ opioid cold meds
FDA is taking its toughest stance yet on opioid-containing cough and cold medications for children.
FDA approves first drug for breast cancer with BRCA gene
FDA approved the first drug to treat certain patients with metastatic breast cancer who have a “BRCA” gene mutation.
Top 3 new drug approvals
Here are 3 of the top new drug approvals in late December and early January.
Drug shortage help on horizon
Drug shortage help on horizon
While hospitals continue to face IV saline shortages after two hurricanes significantly damaged infrastructure in Puerto Rico, the situation should improve early this year.
Top 5 pipeline drugs for 2018
Top 5 pipeline drugs for 2018
New blockbuster drugs to treat various conditions are expected to be among the top drugs to hit the marketplace in 2018. Here are 5 of the top new drugs in the pipeline for 2018, according to analysts.
New treatment for advanced kidney cancer approved
New treatment for advanced kidney cancer approved
FDA expanded the indication on cabozantinib (Cabometyx, Exelixis) to treat patients with advanced renal cell carcinoma (RCC).
FDA okays short-acting follow-on insulin for diabetes
FDA okays short-acting follow-on insulin for diabetes
FDA okays the first short-acting insulin approved as a “follow-on” product.
Integrated care can benefit pediatric asthmatics
A new study reveals interesting findings about improving the health of pediatric asthma patients and integrated care programs.

Poll

View Results